Evidence map›Paper›PMID 31505626›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.

Beckie N Tagbo, Rowan E Bancroft, Iretiola Fajolu, Mohammed B Abdulkadir, Muhammad F Bashir, Olusola P Okunola, Ayodeji H Isiaka, Namadi M Lawal, Benedict O Edelu, Ngozi Onyejiaka and 25 more

Erratum issuedAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Molecular characterization ofMicrobial genomics · 2023
    Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors.

Beckie N TagboInstitute of Child Health, University of Nigeria Teaching Hospital, Ituku-Ozalla, and.
Rowan E BancroftWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Iretiola FajoluDepartment of Paediatrics, Lagos University Teaching Hospital.
Mohammed B AbdulkadirDepartment of Paediatrics and Child Health, University of Ilorin Teaching Hospital.
Muhammad F BashirDepartment of Paediatrics, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi.
Olusola P OkunolaDepartment of Child Health, University of Benin Teaching Hospital.
Ayodeji H IsiakaWHO Country office, Abuja.
Namadi M LawalDepartment of Disease Control and Immunization, National Primary Health Care Development Agency, Abuja.
Benedict O EdeluDepartment of Paediatrics University of Nigeria Teaching Hospital Ituku-Ozalla, Enugu State.
Ngozi OnyejiakaDepartment of Medical Microbiology and Parasitology, Lagos University Teaching Hospital.
Chinonyerem J IhuomaDepartment of Microbiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State.
Florence NduMother of Christ Specialist Hospital Enugu.
Uchenna C OzumbaDepartment of Microbiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State.
Frances UdeinyaDepartment of Microbiology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State.
Folasade OgunsolaDepartment of Medical Microbiology and Parasitology, Lagos University Teaching Hospital.
Aishat O SakaDepartment of Paediatrics and Child Health, University of Ilorin Teaching Hospital.
Abayomi FadeyiDepartment of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, Kwara.
Sunday A AderibigbeDepartment of Epidemiology and Community Health, University of Ilorin Teaching Hospital, Kwara.
Jimoh AbdulraheemDepartment of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, Kwara.
Adamu G YusufMedical Microbiology Department, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi.
Peter Sylvanus NdowWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Philomena OgboguDepartment of Medical Microbiology, University of Benin Teaching Hospital.
Chinomnso KanuDepartment of Community Health, University of Benin Teaching Hospital, and.
Velly EminaDepartment of Community Health and Primary Care, Lagos University Teaching Hospital, Nigeria.
Olajumoke J MakinwaDepartment of Medical Microbiology and Parasitology, Lagos University Teaching Hospital.
Florian GehreDepartment of Paediatrics University of Nigeria Teaching Hospital Ituku-Ozalla, Enugu State.
Kabir YusufDepartment of Disease Control and Immunization, National Primary Health Care Development Agency, Abuja.
Fiona BrakaWHO, Nigeria EPI Cluster Lead.
Jason M MwendaWHO Regional Office for Africa WHO/AFRO, Republic of Congo, Brazzaville.
Johnson M TichaWHO Country office, Abuja.
Dorothy NwodoWHO Country office, Abuja.
Archibald WorwuiWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Joseph N BieyWHO Regional Office for Africa WHO/AFRO, Republic of Congo, Brazzaville.
Brenda A Kwambana-AdamsWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Martin AntonioWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHistorically, Nigeria has experienced large bacterial meningitis outbreaks with high mortality in children. Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae are major causes of this invasive disease. In collaboration with the World Health Organization, we conducted longitudinal surveillance in sentinel hospitals within Nigeria to establish the burden of pediatric bacterial meningitis (PBM).

methodsFrom 2010 to 2016, cerebrospinal fluid was collected from children <5 years of age, admitted to 5 sentinel hospitals in 5 Nigerian states. Microbiological and latex agglutination techniques were performed to detect the presence of pneumococcus, meningococcus, and H. influenzae. Species-specific polymerase chain reaction and serotyping/grouping were conducted to determine specific causative agents of PBM.

resultsA total of 5134 children with suspected meningitis were enrolled at the participating hospitals; of these 153 (2.9%) were confirmed PBM cases. The mortality rate for those infected was 15.0% (23/153). The dominant pathogen was pneumococcus (46.4%: 71/153) followed by meningococcus (34.6%: 53/153) and H. influenzae (19.0%: 29/153). Nearly half the pneumococcal meningitis cases successfully serotyped (46.4%: 13/28) were caused by serotypes that are included in the 10-valent pneumococcal conjugate vaccine. The most prevalent meningococcal and H. influenzae strains were serogroup W and serotype b, respectively.

conclusionsVaccine-type bacterial meningitis continues to be common among children <5 years in Nigeria. Challenges with vaccine introduction and coverage may explain some of these finding. Continued surveillance is needed to determine the distribution of serotypes/groups of meningeal pathogens across Nigeria and help inform and sustain vaccination policies in the country.

Indexed as

Sentinel SurveillanceChild, PreschoolCost of IllnessFemaleHaemophilus influenzaeHospitalizationHumansInfantInfant, NewbornLongitudinal StudiesMaleMeningitis, BacterialNeisseria meningitidisNigeriaPneumococcal VaccinesSerogroup10-valent pneumococcal conjugate vaccinePneumococcal VaccinesmeningitismeningococcusneumococcusNigeriapediatric

Identifiers

PMID31505626
PMCPMC6736152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.